Рress release is available only in Russian https://gmpnews.ru/2020/07/pochemu-v-rossii-ne-rabotaet-sistema-pravil-nadlezhashhej-laboratornoj-praktiki/
Рress release is available only in Russian https://gmpnews.ru/2020/07/farmrynok-zhdet-edinogo-regulyatora-v-oblasti-glp-inspekcij/
Details in the article https://gmpnews.ru/2020/04/chto-meshaet-vnedreniyu-glp-v-rossii/ [full text is available in Russian]
Great news! 50 days’ free access to the article Therapeutic efficacy of arginine-rich exenatide on diabetic neuropathy in rats before January 29, 2020. No sign up, registration or fees are required.
Final version of article https://authors.elsevier.com/c/1aCra3G5rd5HX
The Editors of Peptides, Olson Prize Selection Committee, and Elsevier Inc., are proud to announce that Valery G. Makarov has been selected as the 2018 winner of the GAYLE A. OLSON & RICHARD D. OLSON PRIZE awarded to the senior author of the most meritorious original research article published during the previous year in Peptides. Congratulations Professor Makarov! The winning article “A new tridecapeptide with an octaarginine vector has analgesic therapeutic potential and prevents morphine-induced tolerance” authored by Vladimir A. Kashkin, Elena V. Shekunova, Michail I. Titov, Ivan I. Eliseev, Maxim A. Gureev, Yuri B. Porozov, Marina N. Makarova, Valery G. Makarov was published in Peptides Volume 99 (January 2018) and has been made freely accessible until May 2020.
IV all-Russia GMP CONFERENCE with international participation took place on 23-25 September 2019 in Svetlogorsk, Kaliningrad region. Our experts participated in the plenary discussion and discussed issues of: сhallenges of implementing Good Pharmacy Practice (GPP) in Russian and Eurasian Economic Union, their possible reasons and implications, statutory documents in the system of regulatory lifecycle of drugs in Russian and Eurasian Economic Union, ensuring the quality of pre-clinical trials of drugs from the Good Pharmacy Practice (GPP) perspective, сlinical trials in Russia: from harmonization of Good Clinical Practice (GCP) to recognition of the results of clinical trials abroad, Russia’s experience of implementing GMP in Russia.